| Aug 1 |
Regenxbio GAAP EPS of -$1.05 beats by $0.20, revenue of $22.3M misses by $0.67M
|
| Aug 1 |
REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
|
| Aug 1 |
REGENXBIO releases new data on DMD drug ahead of earnings
|
| Aug 1 |
REGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202
|
| Jul 31 |
Regenxbio Q2 2024 Earnings Preview
|
| Jul 30 |
Insider Sale: CEO Curran Simpson Sells Shares of Regenxbio Inc (RGNX)
|
| Jul 25 |
REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights
|
| Jul 12 |
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
|
| Jul 8 |
Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD
|
| Jun 27 |
Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth?
|
